|
|||||||||||||||
|
|||||||||||||||
 |
|||||||||||||||
Sexually
Transmitted Diseases > Research > Douglas,
John
John Munroe Douglas, Jr., MD
Dr. Douglas is a leader in the field of STD prevention, nationally recognized for his contributions in applied research on the epidemiology and treatment of STDs, for the implementation of research findings into effective STD prevention program practice, and for effective STD prevention program policy development. Prior to joining CDC in 2003, Dr. Douglas served in a combination of key management, science, and medical positions for the Denver Department of Health and Hospitals (now Denver Health). These include Director of STD Control; Director, Denver Public Health Virology Laboratory; Attending Physician in Medicine and Infectious Diseases, Denver General Hospital (now Denver Health Medical Center); and the Medical Director of the Denver STD Prevention Training Center. While at Denver Health he also held various academic appointments at the University of Colorado Health Sciences Center. In 1996 he was named Clinical Teacher of the Year for the Division of Infectious Diseases, and in 1999 he was appointed full Professor, Departments of Medicine and Biometrics and Preventive Medicine. Dr. Douglas earned his BA degree in English, Summa Cum Laude, from Davidson College, North Carolina, in 1974, and his MD from Harvard Medical School in 1978. He completed his internship and residency in Internal Medicine at the University of Washington Affiliated Hospitals in 1981, where he also served as Chief Medical Resident before completing his fellowship in 1984 with the Division of Infectious Diseases, University of Washington Affiliated Hospitals.
Selected Publications Pealer LN, Peterman TA, Newman DR, Kamb ML, Dillon B, Malotte CK, Zenilman
J, Douglas JM, Bolan G, for the Project RESPECT Study Group. Are
counselor demographics associated with successful human immunodeficiency
virus/sexually transmitted diseases prevention counseling? Sexually
Transmitted Diseases 2004;31(1):52-56. Shlay JC, Merino M, Douglas JM. Comparison of sexually transmitted
disease prevalence by reported level of condom use among patients attending
an urban sexually transmitted disease clinic. Sexually
Transmitted Diseases 2004;31(3):154-160. Corey L, Wald A, Patel R, Sacks SL, Trying SK, Warren T, Douglas JM Jr.,
et al. Once-daily valacyclovir to reduce the risk of transmission
of genital herpes. New England Journal of Medicine 2004;350(1):11-20. Warner L, Newman DR, Austin HA, Kamb ML, Douglas JM, Malotte CK, Zenilman
JM, Rogers J, Bolan G, Fishbein M, Kleinbaum DG, Macaluso M, Peterman
TA, for the Project RESPECT Study Group. Condom effectiveness
for reducing transmission of gonorrhea and chlamydia: The importance of
assessing partner infection status. American Journal of Epidemiology 2004;159(3):242-251. Weinstock Hillard S, MD, Zaidi I, Heneine W, Bennett D, Garcia-Lerma
G, Douglas JM, et al. The epidemiology of antiretroviral drug
resistance among drug-naïve HIV-1 infected persons in 10 U. S. cities. Journal
of Infectious Diseases 2004;189(12):2174-2180.
|
|||||||||||||||
Content provided by the Division of STD Prevention |
|||||||||||||||
|
|||||||||||||||
|
